Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US task force recommendations
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
An international task force of academic and industry leaders in sarcopenia research met on December 5, 2012 in Orlando, Florida to develop guidelines for designing and executing randomized clinical trials of sarcopenia treatments. The Task Force reviewed results from previous trials in related disease areas to extract lessons relevant to future sarcopenia trials, including practical issues regarding the design and conduct of trials in elderly populations, the definition of appropriate target populations, and the selection of screening tools, outcome measures, and biomarkers. They discussed regulatory issues, the challenges posed by trials of different types of interventions, and the need for standardization and harmonization. The Task Force concluded with recommendations for advancing the field toward better clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gait speed and survival in older adults.
Studenski, S. (2011) · JAMA · doi:10.1001/jama.2010.1923 · Cited by 4,558
Self-citationFielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Self-citationFRAX™ and the assessment of fracture probability in men and women from the UK
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., & McCloskey, E. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0543-5 · Cited by 2,467
Muscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732
Weight loss, exercise, or both and physical function in obese older adults
Villareal, D. T., Chode, S., Parimi, N., Sinacore, D. R., Hilton, T., Armamento-Villareal, R., Napoli, N., Qualls, C., & Shah, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008234 · Cited by 1,096 · cited 1×
“Other clinical trials randomized obese older adults into four groups: weight management alone, exercise training alone, a combination of weight management and exercise training, or a control group; these trials showed that while diet alone increased physical performance, the combination of diet and exercise produced e…”
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Self-citationMessier, S. P., Loeser, R. F., Miller, G. D., Morgan, T. M., Rejeski, W. J., Sevick, M. A., Ettinger, W. H., Pahor, M., & Williamson, J. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20256 · Cited by 1,065
Self-citationEffect of 10 Days of Bed Rest on Skeletal Muscle in Healthy Older Adults
Kortebein, P., Ferrando, A., Lombeida, J., Wolfe, R., & Evans, W. J. (2007) · JAMA · doi:10.1001/jama.297.16.1772-b · Cited by 933 · cited 1×
“elderly patients lose about a kilogram of muscle mass along with significant loss of function (30).”
Self-citationAn overview of sarcopenia: facts and numbers on prevalence and clinical impact
von Haehling, S., Morley, J. E., & Anker, S. D. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0014-2 · Cited by 888 · cited 1×
“Prevalence estimates range from 5-13% among 60-70 years old, and as high as 11-50% in those over age 80 (2).”
Self-citationKosek, D. J., Kim, J.-S., Petrella, J. K., Cross, J. M., & Bamman, M. M. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01474.2005 · Cited by 503 · cited 1×
“Exercise training has been tested in many trials for its ability to slow the decline of muscle function in older adults (12-15).”
Cited by
Bischoff-Ferrari, H. A., Orav, J. E., Kanis, J. A., Rizzoli, R., Schlögl, M., Staehelin, H. B., Willett, W. C., & Dawson-Hughes, B. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3194-y · Cited by 332
Fragala, M. S., Kenny, A. M., & Kuchel, G. A. (2015) · Sports Medicine · doi:10.1007/s40279-015-0305-z · Cited by 246
“pharmaceutical trials for sarcopenia [193].”
BackgroundZhu, L.-Y., Chan, R., Kwok, T., Cheng, K. C.-C., Ha, A., & Woo, J. (2019) · Age and Ageing · doi:10.1093/ageing/afy179 · Cited by 179
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
Reginster, J.-Y., Cooper, C., Rizzoli, R., Kanis, J. A., Appelboom, G., Bautmans, I., Bischoff-Ferrari, H. A., Boers, M., Brandi, M. L., Bruyère, O., et al. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0517-y · Cited by 112
Self-citationTranslational Geroscience: Emphasizing function to achieve optimal longevity
Seals, D. R., & Melov, S. (2014) · Aging · doi:10.18632/aging.100694 · Cited by 90
“Indeed, modeling of assessments of “functional status” in humans that are most likely to be approved by regulatory authorities for future clinical trials of healthspan-extending pharmaceutical agents in at-risk older adults should be a key goal [37, 40, 41, 48, 49].”
BackgroundMethod
Metadata
- Authors
- Vellas, B., Pahor, M., Manini, T., Rooks, D., Guralnik, J. M., Morley, J., Studenski, S., Evans, W., Asbrand, C., Fariello, R., Pereira, S., Rolland, Y., Abellan Van Kan, G., Cesari, M., Chumlea, W. M. C., & Fielding, R.
- Venue
- The Journal of nutrition, health and aging
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 17
- Issue
- 7
- Pages
- 612-618
- ISSN
- 1279-7707 (ISSN-L)
- OpenAlex
- W1977946208
- Cited by
- 43
- References
- 20
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US task force recommendations. https://app.cochat.ai/papers/10.1007/s12603-013-0362-7
- The paper
- Vellas, B., Pahor, M., Manini, T., Rooks, D., Guralnik, J. M., Morley, J., Studenski, S., Evans, W., Asbrand, C., Fariello, R., Pereira, S., Rolland, Y., Abellan Van Kan, G., Cesari, M., Chumlea, W. M. C., & Fielding, R. (2013). Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US task force recommendations. The Journal of nutrition, health and aging. https://doi.org/10.1007/s12603-013-0362-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.